This inventor holds 3 USPTO granted patents. Top assignees: Glycorex Ab, Hoechst Aktiengesellschaft. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mainz, DE (1999)
- Gustavsburg, DE (2001 - 2002)
Company Filing History:
Years Active: 1999-2002
Title: **The Innovations of Ulrich Sprengard: Pioneering Glycomimetics**
Introduction
Ulrich Sprengard, an innovative inventor based in Gustavsburg, Germany, has made significant contributions to the field of pharmaceuticals through his work on glycomimetics. With a count of three patents under his name, Sprengard is recognized for his groundbreaking research in developing inhibitors of cell adhesion that have potential therapeutic applications.
Latest Patents
Sprengard's most recent patents include the innovations titled "Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity." These inventions focus on novel mimetics of the tetrasaccharides sialyl-Lewis-X and sialyl-Lewis-A. The work highlights improved actions as inhibitors of cell adhesion, emphasizing a novel approach to address anti-inflammatory activity. The patents also detail processes for preparing these compounds and exploring their uses as pharmacologically active agents and diagnostic tools.
Career Highlights
Throughout his career, Sprengard has collaborated with prominent companies such as Glycorex AB and Hoechst Aktiengesellschaft. His work at these organizations has undoubtedly shaped his expertise, allowing him to become a recognized figure in the realm of pharmaceutical innovation. The combination of his research and practical applications of glycomimetics positions him as a valuable contributor to contemporary medicine.
Collaborations
In his journey as an inventor, Sprengard has worked alongside esteemed colleagues, Gerhard Kretzschmar and Wolfgang Schmidt. These collaborations have fostered an environment of shared innovation and scientific inquiry, further enhancing the impact of their collective work within the industry.
Conclusion
Ulrich Sprengard's contributions to the field of glycomimetics exemplify the spirit of innovation and the importance of scientific exploration in developing new therapeutic solutions. As he continues to expand the boundaries of pharmaceutical research, his work remains a testament to the vital role inventors play in advancing healthcare and improving lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile